DISCOUNT-ZERTIFIKAT - FRESENIUS Share Price

Certificat

DE000KH2Y1Z3

Market Closed - Deutsche Boerse AG 18:26:42 27/05/2024 BST
22.9 EUR +0.04% Intraday chart for DISCOUNT-ZERTIFIKAT - FRESENIUS
Current month+0.84%
1 month+0.93%
Date Price Change
27/05/24 22.9 +0.04%
24/05/24 22.89 0.00%
23/05/24 22.89 +0.04%
22/05/24 22.88 +0.09%
21/05/24 22.86 -0.04%

Delayed Quote Deutsche Boerse AG

Last update May 27, 2024 at 06:26 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer Citi Citi
WKN KH2Y1Z
ISINDE000KH2Y1Z3
Date issued 27/01/2023
Cap 23
Last trading day 20/06/2024
Maturity 20/06/2024 (24 Days)
Parity 1 : 1
Emission price 19.67
Emission volume N/A
Payment day 25/06/2024
Bonus-
Settlement les deux
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point-
Break even 0.000000 €
Highest since issue 22.91
Lowest since issue 18.96
Distance Cap 6.2
Distance Cap %+21.23%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.2 EUR
Average target price
36.72 EUR
Spread / Average Target
+25.77%
Consensus